Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations by Kristin Palmsten (427039)

Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19 by Liviu Cojocaru (11849812)

Pol I Is Required for Adaptive Amplification and Not Point Mutation by P. J Hastings (5229)

“…<div><p>Strains were plated on lactose-minimal medium and Lac⁺ colonies counted daily (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0020399#s3" target="_blank">Materials and Methods</a>). …”

Genome-wide CRISPRi screen to reveal proteins and pathways impacting PF8503 toxicity in K562 cells. by Nadège Liaud (6470615)

“…Promoters in the lentiviruses for sgRNA (murine U6, mU6) and Puromycin resistance cassette (EF1α) are shown [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008057#pgen.1008057.ref017" target="_blank">17</a>]. …”

Variations in the mitochondrial network of melanoma-associated and normal skin fibroblasts. by Sophie Charrasse (14885066)

“…White squares indicate zoomed areas shown in insets. Scale bar = 10μm. <b>(B)</b> MitoSpider plot and cognate MitoSigil inferred after analysis by MitoTouch show cellular retraction (significant decrease in Cell_Area, small circle *: p<0.05) with concomitant ramification of the mitochondrial network (significant increase in the Skel_EndPointsCount parameter, small circle *: p<0.05) in cancer cells (purple line) compared to their normal counterparts (green circle). …”

Interaction of FKBP8 with ER specific protein and FKBP8 expression in mitochondria fraction during mitophagy. by Michael O. Isei (20500908)

“…<p>Dual staining for FKBP8 (red) and BiP/GrP78 (green) was performed to analyze their colocalization in unstressed cells <b>(A)</b> and cells induced for mitophagy with PQ for 6 h <b>(B)</b>. …”

wek knock-down caused DAN loss in the absence of infection. by Deepanshu N. D. Singh (20721878)

“…<p><i>wek-RNAi</i> knock-down caused a decrease in TH + DANs PPL1 <b>(A)</b> and PPL2 <b>(B),</b> that was not rescued with the over-expression of <i>wek</i> caused by <i>B. bassiana</i> infection, suggesting that <i>wek</i> is required for DAN differentiation. …”

DNA–protein complexes generated by Cdc13 and CST. by Neal F. Lue (17075)

“…(B) The stability of the CST-DNA complex was estimated in a competition experiment. CST (10 nM) was allowed to form complexes with labeled CgTELX1 (7.5 nM) for 20 min. …”

Stability and Viscoelasticity of Magneto-Pickering Foams by Elena Blanco (1926052)

Stability and Viscoelasticity of Magneto-Pickering Foams by Elena Blanco (1926052)

Stability and Viscoelasticity of Magneto-Pickering Foams by Elena Blanco (1926052)

Stability and Viscoelasticity of Magneto-Pickering Foams by Elena Blanco (1926052)

AID induces demethylation independent of the nucleotide context. by Don-Marc Franchini (266869)

“…Supercoiled plasmids (<i>m6A(+</i>) as isolated from standard <i>E. coli</i>) were subjected to IVR assays containing GAL4-AID as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097754#pone-0097754-g001" target="_blank">Figure 1</a>. …”

Tracking Membrane Protein Association in Model Membranes by Myriam Reffay (265498)

Characteristics of the latent classes. by Zhongheng Zhang (552412)

“…Each question was followed by an answer annotated by uppercase letters such as A, B, C, D and E. Annotations: how to assess the effectiveness of aerosol therapy (AssessEffect.How): A: Waveform B: Breathing sound C: Inspection of breathing appearance D: Not assess routinely E: others Filter exchange frequency (FilterExchange.frq) A: Every time after nebulization B: Once daily C: Twice a week D: Once a week E: More than once a week Nebulizer position for Metered dose nebulization (FixedDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Use of holding chambers / spacers for metered dose nebulization (FixedDose.Container) A: yes B: no C: never use Use of aerosol therapy for invasive mechanical ventilation (IMV.nebulization.flg) A: Yes Type of jet nebulizer (JetNebulizer.type) A: external gas source B: external nebulizer pump C: nebulizer within ventilator D: others Nebulizer position for small-volume nebulizer (LowDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Change of MV setting during nebulization (MVparameter.onNebu) A: Never change B: Increase PEEP C: Decrease inspiratory flow D: Use constant inspiratory flow E: Increase inspiratory time F: Use inspiratory pause G: Increase tidal volume H: Stop heated humidifier I: Place filter on expiratory circuit J: Sedation to avoid dyssynchrony K: Use base flow rate L: Others Type of nebulization drug (Nebu.Drug) A: bronchodilators B: antibiotics C: mucolytic agent D: topical steroids E: systemic steroids F: others Type of nebulizer (Nebulizer.type) A: ultrasonic nebulizer B: jet nebulizer C: vibrating mesh nebulizer D: metered dose E: others Use of protocol for aerosol therapy (NebuProtocal.flg) A: yes Use of nebulization during noninvasive mechanical ventilation (NIMV.nebulization.flg) A: yes PEEP level during aerosol therapy (PEEP.onNebu) A: 0 B: 1–5 C: 6–10 D: >10 E: PEEP not changed Model of ventilator setting during aerosol therapy (SpecialNebu) A: Pressure control B: Pressure support C: volume control D: SIMV E: High-frequency ventilation F: others.…”

<i>In Vitro</i> Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites by Eliska Potuckova (525220)

Effect of 1,25(OH)₂D3 on the production of KIM-1 and fibronectin 1 from HRPTEpiC induced by recombinant human IL-17 (rhIL-17), human TNF- α or TGF-beta. by Byung Ha Chung (314449)

“…<p><b>(A)</b> The expression of KIM-1 by HRPTEpiC was pretreated with 1,25(OH)₂D3 (10 nM) as indicated, and then cultured for 24 hours with TNF-α (50 ng/mL) and/or IL-17 (50ng/mL) (n = 3). …”

Data_Sheet_1_Predictors and Changes in Paternal Perinatal Depression Profiles—Insights From the DREAM Study.PDF by Susan Garthus-Niegel (3555482)

“…We found that rates of paternal depression symptoms decreased with 9% during pregnancy to 5% at 8 weeks postpartum. …”

NS2 transmembrane region enables the NS2-E2 interaction. by Costin-Ioan Popescu (230609)

S1 Data - by Xiaowei Zhang (6505)